Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1-lauryl-2-pyrrolidone
1. 1-dodecylpyrrolidin-2-one
2. 2687-96-9
3. Lauryl Pyrrolidone
4. 1-lauryl-2-pyrrolidone
5. N-dodecylpyrrolidinone
6. N-lauryl-2-pyrrolidone
7. 2-pyrrolidinone, 1-dodecyl-
8. N-dodecyl-2-pyrrolidone
9. 1-dodecyl-2-pyrrolidone
10. N-(n-dodecyl)pyrrolidinone
11. 3p14vw8fny
12. Unii-3p14vw8fny
13. Brn 0155011
14. Laurylpyrrolidone
15. N-dodecylpyrrolidone
16. Oristar Lpl
17. N-dodecylpyrrolidin-2-one
18. Ec 403-730-1
19. Surfadone Lp-300
20. Dsstox_cid_22206
21. Dsstox_rid_79957
22. Dsstox_gsid_42206
23. Schembl43383
24. Chembl3186490
25. Dtxsid4042206
26. 1-n-dodecylazacyclopentan-2-one
27. Lauryl Pyrrolidone [inci]
28. Chebi:146192
29. 1-dodecyl-2-pyrrolidinone, 99%
30. Zinc1849929
31. Tox21_300374
32. Mfcd00075066
33. Akos015898211
34. Cs-w012601
35. Ncgc00248010-01
36. Ncgc00254270-01
37. Bs-16757
38. Cas-2687-96-9
39. Ft-0652497
40. Ft-0654021
41. D70538
42. A818649
43. J-504832
44. Q27257840
| Molecular Weight | 253.42 g/mol |
|---|---|
| Molecular Formula | C16H31NO |
| XLogP3 | 5.4 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 1 |
| Rotatable Bond Count | 11 |
| Exact Mass | 253.240564612 g/mol |
| Monoisotopic Mass | 253.240564612 g/mol |
| Topological Polar Surface Area | 20.3 Ų |
| Heavy Atom Count | 18 |
| Formal Charge | 0 |
| Complexity | 215 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Market Place
ABOUT THIS PAGE
A Surfadone LP-300 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Surfadone LP-300, including repackagers and relabelers. The FDA regulates Surfadone LP-300 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Surfadone LP-300 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Surfadone LP-300 supplier is an individual or a company that provides Surfadone LP-300 active pharmaceutical ingredient (API) or Surfadone LP-300 finished formulations upon request. The Surfadone LP-300 suppliers may include Surfadone LP-300 API manufacturers, exporters, distributors and traders.
click here to find a list of Surfadone LP-300 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Surfadone LP-300 DMF (Drug Master File) is a document detailing the whole manufacturing process of Surfadone LP-300 active pharmaceutical ingredient (API) in detail. Different forms of Surfadone LP-300 DMFs exist exist since differing nations have different regulations, such as Surfadone LP-300 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Surfadone LP-300 DMF submitted to regulatory agencies in the US is known as a USDMF. Surfadone LP-300 USDMF includes data on Surfadone LP-300's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Surfadone LP-300 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Surfadone LP-300 suppliers with USDMF on PharmaCompass.
Surfadone LP-300 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Surfadone LP-300 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Surfadone LP-300 GMP manufacturer or Surfadone LP-300 GMP API supplier for your needs.
A Surfadone LP-300 CoA (Certificate of Analysis) is a formal document that attests to Surfadone LP-300's compliance with Surfadone LP-300 specifications and serves as a tool for batch-level quality control.
Surfadone LP-300 CoA mostly includes findings from lab analyses of a specific batch. For each Surfadone LP-300 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Surfadone LP-300 may be tested according to a variety of international standards, such as European Pharmacopoeia (Surfadone LP-300 EP), Surfadone LP-300 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Surfadone LP-300 USP).
LOOKING FOR A SUPPLIER?
